Drugs / F027
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07046273 | Aug 2025 → Aug 2028 expected | type 2 diabetes mellitus | Shandong New Time Pharmaceutical Co., LTD | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F027 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07046273 ↗ |